HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Victor L J L Thijssen Selected Research

Biomarkers (Surrogate Marker)

1/2024A Comparative Analysis of Local and Systemic Immunological Biomarkers in Females With Breast Implants and Capsular Contracture.
1/2021Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Victor L J L Thijssen Research Topics

Disease

18Neoplasms (Cancer)
01/2024 - 10/2004
2Inflammation (Inflammations)
01/2024 - 01/2021
2Carcinoma (Carcinomatosis)
01/2019 - 10/2004
1Contracture
01/2024
1Fibrosis (Cirrhosis)
01/2024
1Renal Cell Carcinoma (Grawitz Tumor)
01/2023
1Esophageal Neoplasms (Esophageal Cancer)
11/2022
1Adenocarcinoma
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Heart Failure
10/2011
1Myocardial Infarction
10/2011
1Infarction (Infarctions)
10/2011
1Carcinogenesis
10/2007
1Neoplasm Metastasis (Metastasis)
10/2007
1Breast Neoplasms (Breast Cancer)
11/2004
1Ductal Carcinoma
11/2004
1Medullary Carcinoma
11/2004
1Atrial Fibrillation
08/2004
1Endometriosis
03/2004

Drug/Important Bio-Agent (IBA)

4Angiogenesis InhibitorsIBA
10/2006 - 03/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 03/2004
3Proteins (Proteins, Gene)FDA Link
10/2007 - 08/2005
2Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2021
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2023 - 11/2004
2Galectins (Galectin)IBA
11/2022 - 10/2007
2Galectin 1 (LGALS1)IBA
01/2021 - 10/2006
2Protein Isoforms (Isoforms)IBA
01/2019 - 08/2004
21-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
03/2014 - 10/2006
2Peptides (Polypeptides)IBA
04/2006 - 08/2005
2EndostatinsIBA
04/2006 - 03/2004
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2004 - 10/2004
1N 30IBA
01/2024
1SiliconesIBA
01/2024
1Bevacizumab (Avastin)FDA Link
01/2023
1Sunitinib (Sutent)FDA Link
01/2023
1CytokinesIBA
01/2023
1Carrier Proteins (Binding Protein)IBA
11/2022
1Polysaccharides (Glycans)IBA
11/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1CarbohydratesIBA
01/2021
1LectinsIBA
01/2021
1InterferonsIBA
01/2020
1Conjugate VaccinesIBA
01/2019
1AntibodiesIBA
01/2019
1Peptide FragmentsIBA
10/2011
1Wnt ProteinsIBA
10/2011
1Frizzled ReceptorsIBA
10/2011
1LigandsIBA
05/2007
1Recombinant ProteinsIBA
10/2006
1Paclitaxel (Taxol)FDA LinkGeneric
04/2006
1AngiostatinsIBA
04/2006
1SuspensionsIBA
11/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2004
1Vascular Endothelial Growth Factor CIBA
11/2004
1Vascular Endothelial Growth Factor DIBA
11/2004
1AngiopoietinsIBA
11/2004
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2004
1Angiopoietin-1IBA
10/2004
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2004
1Vascular Endothelial Growth FactorsIBA
10/2004
1Neuropilin-1IBA
10/2004
1Troponin IIBA
08/2004
1Peptide Hydrolases (Proteases)FDA Link
08/2004
1O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
03/2004

Therapy/Procedure

8Therapeutics
01/2024 - 03/2004
3Radiotherapy
01/2020 - 01/2018
2Immunotherapy
01/2018 - 04/2006
1Breast Implants (Breast Implant)
01/2024
1Neoadjuvant Therapy
01/2021
1Subcutaneous Injections
10/2006